Market Research Logo

Novavax, Inc.

Novavax, Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Novavax, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
  • Intelligence on Novavax, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Novavax, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Novavax (or 'the company') is a biopharmaceutical company focused on developing recombinant vaccines. The company's technology platform is based on recombinant nanoparticle vaccine technology that includes virus-like particles (VLPs) and protein nanoparticles. Novavax operates in the US where it is headquartered in Rockville, Maryland. It employed 308 people as on February 23, 2015.Reasons to Purchase:

  • Gain understanding of Novavax, Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Novavax, Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Novavax, Inc.’s business structure, strategy and prospects

  • Company Snapshot
    Novavax, Inc.: Company Overview
    Novavax, Inc.: Overview and Key Facts
    Novavax, Inc.: Overview
    Novavax, Inc.: Key Facts
    Novavax, Inc.: Key Employees
    Novavax, Inc.: Key Employee Biographies
    Novavax, Inc.: Major Products and Services
    Novavax, Inc.: Company History
    Novavax, Inc.: Management Statement
    Novavax, Inc.: Locations and Subsidiaries
    Novavax, Inc.: Key Competitors
    Novavax, Inc.: Company Analysis
    Novavax, Inc.: Business Description
    Novavax, Inc.: SWOT Analysis
    Novavax, Inc.: SWOT Overview
    Novavax, Inc.: Strengths
    Novavax, Inc.: Weaknesses
    Novavax, Inc.: Opportunities
    Novavax, Inc.: Threats
    Novavax, Inc.: Corporate Financial Deals Activity
    Novavax, Inc.: Financial Deals Overview
    Novavax, Inc.: Targets and Partners
    Novavax, Inc.: Top Deals 2011 - 2015YTD*
    Novavax, Inc.: Advisors
    Novavax, Inc.: Top Legal Advisors
    Novavax, Inc.: Top Financial Advisors
    Novavax, Inc.: Mergers and Acquisitions
    Novavax, Inc.: Capital Raising
    Novavax, Inc.: Partnership
    Novavax, Inc.: Private Equity and Ownership
    Novavax, Inc.: Recent Developments
    Novavax, Inc.: News and Events Summary
    Novavax, Inc.: Corporate Governance
    Novavax, Inc.: Financial Performance
    Novavax, Inc.: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Novavax, Inc.: Key Facts
    Table 2: Novavax, Inc.: Key Employees
    Table 4: Novavax, Inc.: Key Competitors
    Table 5: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
    Table 8: Novavax, Inc.: Targets and Partners
    Table 9: Novavax, Inc.: Top Deals 2011 - 2015YTD*
    Table 10: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
    Table 11: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
    Table 12: Novavax, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 13: Novavax, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Table 14: Novavax, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Table 15: Novavax, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Table 16: Novavax, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 17: Novavax, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 18: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Table 19: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
    Table 20: Novavax, Inc.: News and Events Summary
    Table 21: Novavax, Inc.: Corporate Governance
    Table 22: Novavax, Inc.: Financial Performance
    Table 23: Novavax, Inc.: Research & Development
    List of Figures
    Figure 1: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Novavax, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
    Figure 4: Novavax, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 5: Novavax, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Figure 6: Novavax, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Figure 7: Novavax, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Figure 8: Novavax, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 9: Novavax, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 10: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Figure 11: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report